Deadly complication of stem cell transplants reduced in mice
Studying leukemia in mice, John F. DiPersio, MD, PhD, and his colleagues at Washington University School of Medicine in St. Louis, have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns.
Decoding cancer patients’ genomes is powerful diagnostic tool
Two new studies in the Journal of the American Medical Association by Washington University researchers including Timothy Ley, MD, and Richard Wilson, PhD, highlight the power of sequencing cancer patients’ genomes as a diagnostic tool, helping doctors decide the best course of treatment and researchers identify new cancer susceptibility mutations that can be passed from parent to child.
Mouse cancer genome unveils genetic errors in human cancers
By sequencing the genome of a mouse with cancer, researchers at the School of Medicine have uncovered mutations that also drive cancer in humans.
Washington University, St. Jude team to unravel genetic basis of childhood cancers
Washington University School of Medicine and St. Jude Children’s Research Hospital announced in a Jan. 25 news conference in Washington, D.C., an unprecedented effort to identify the genetic changes that give rise to some of the world’s deadliest childhood cancers.